First human test for potential myopia eye drop
NCT ID NCT05470881
Summary
This study tested the safety of a new eye drop called PRO-201 in 29 healthy volunteers. The goal was to see how well people tolerated the drops and to check for side effects like light sensitivity. This is an early, first-in-human study to gather basic safety information before testing in people with nearsightedness (myopia).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IIMET Investigación e Innovación en Medicina Traslacional
Guadalajara, Jalisco, 44610, Mexico
Conditions
Explore the condition pages connected to this study.